Background Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen that
poses dangerous health threat. It is a main cause of biofilm-associated infections that are …

In recent decades, bioactive peptides have been gaining recognition in various biomedical
areas, such as intracellular drug delivery (cell-penetrating peptides, CPPs) or anti-infective …

Introduction: Bacterial resistance is a worldwide public health problem, requiring new
therapeutic options. An alternative approach to this problem is the use of animal toxins …

The present study evaluated intracellular antibacterial efficacy of two short-chain cationic
antimicrobial peptides (AMPs) namely, Cecropin A (1–7)-Melittin and lactoferricin (17–30) …

A large body of evidence accumulating in the past few years indicates the physiological
significance of non-histone proteins lysine methylation, catalyzed by protein lysine methyl …

Acinetobacter baumannii (A. baumannii) is a Gram‐negative, nonmotile, and aerobic
bacillus emerged as a superbug, due to increasing the possibility of infection and …

A global upsurge in antibiotic-resistant Acinetobacter baumannii requires supervised
selection of biocides and disinfectants to avert nosocomial infections by reducing its spread …

The efficient preparation of novel bioactive peptide drugs requires the availability of reliable
and accessible chemical methodologies together with suitable analytical techniques for the …

The swift killing kinetics is an attractive characteristics of wide-spectrum antimicrobial activity
of peptides, which made them generate great attention as possible antitoxin pharmaceutics …

A bioactive containing packaging system is not only a traditional protective structure for a
food product but also offers additional health-benefiting properties. Postbiotics (nonbiotics) …